Literature DB >> 23934277

Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.

Prem Khanal1, Garam Kim, Sung-Chul Lim, Hyo-Jeong Yun, Kwang Youl Lee, Hoo-Kyun Choi, Hong Seok Choi.   

Abstract

Pin1, a conserved eukaryotic peptidyl-prolyl cis/trans isomerase, has profound effects on numerous key-signaling molecules, and its deregulation contributes to disease, particularly cancer. Although Pin1-mediated prolyl isomerization of protein servers as a regulatory switch in signaling pathways, the significance of proline isomerase activity in chromatin modifying complex remains unclear. Here, we identify Pin1 as a key negative regulator for suppressor of variegation 3-9 homologue 1 (SUV39H1) stability, a major methyltransferase responsible for histone H3 trimethylation on Lys9 (H3K9me3). Pin1 interacts with SUV39H1 in a phosphorylation-dependent manner and promotes ubiquitination-mediated degradation of SUV39H1. Consequently, Pin1 reduces SUV39H1 abundance and suppresses SUV39H1 ability to induce H3K9me3. In contrast, depletion of Pin1 in cancer cells leads to elevated SUV39H1 expression, which subsequently increases H3K9me3, inhibiting tumorigenecity of cancer cells. In a xenograft model with 4T1 metastatic mouse breast carcinoma cells, Pin1 overexpression increases tumor growth, whereas SUV39H1 overexpression abrogates it. In human breast cancer patients, immunohistochemical staining shows that Pin1 levels are negatively correlated with SUV39H1 as well as H3K9me3 levels. Thus, Pin1-mediated reduction of SUV39H1 stability contributes to convey oncogenic signals for aggressiveness of human breast cancer, suggesting that Pin1 may be a promising drug target for anticancer therapy.

Entities:  

Keywords:  H3K4me3; H3K9me3; cis/trans isomerase; histone methyltransferases; ubiquitination

Mesh:

Substances:

Year:  2013        PMID: 23934277     DOI: 10.1096/fj.13-236851

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  19 in total

Review 1.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 2.  A drive in SUVs: From development to disease.

Authors:  Vinay Kumar Rao; Ananya Pal; Reshma Taneja
Journal:  Epigenetics       Date:  2017-01-20       Impact factor: 4.528

Review 3.  Prolyl isomerase Pin1 in cancer.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Cell Res       Date:  2014-08-15       Impact factor: 25.617

Review 4.  Zebrafish Discoveries in Cancer Epigenetics.

Authors:  Yelena Chernyavskaya; Brandon Kent; Kirsten C Sadler
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 5.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

6.  An HP1 isoform-specific feedback mechanism regulates Suv39h1 activity under stress conditions.

Authors:  Helena Raurell-Vila; Laia Bosch-Presegue; Jessica Gonzalez; Noriko Kane-Goldsmith; Carmen Casal; Jeremy P Brown; Anna Marazuela-Duque; Prim B Singh; Lourdes Serrano; Alejandro Vaquero
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

7.  TIP60/P400/H4K12ac Plays a Role as a Heterochromatin Back-up Skeleton in Breast Cancer.

Authors:  Mouhamed Idrissou; Tiphanie Boisnier; Anna Sanchez; Fatma Zohra Houfaf Khoufaf; Frederique Penault-Llorca; Yves-Jean Bignon; Dominique Bernard-Gallon
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

8.  Exposure to lard-based high-fat diet during fetal and lactation periods modifies breast cancer susceptibility in adulthood in rats.

Authors:  Fábia de Oliveira Andrade; Camile Castilho Fontelles; Mariana Papaléo Rosim; Tiago Franco de Oliveira; Ana Paula de Melo Loureiro; Jorge Mancini-Filho; Marcelo Macedo Rogero; Fernando Salvador Moreno; Sonia de Assis; Luiz Fernando Barbisan; Leena Hilakivi-Clarke; Thomas Prates Ong
Journal:  J Nutr Biochem       Date:  2014-03-12       Impact factor: 6.048

9.  Variants of ubiquitin-specific peptidase 24 play a crucial role in lung cancer malignancy.

Authors:  Y-C Wang; S-A Wang; P-H Chen; T-I Hsu; W-B Yang; Y-P Chuang; W-C Su; H-J Liaw; W-C Chang; J-J Hung
Journal:  Oncogene       Date:  2015-11-16       Impact factor: 9.867

Review 10.  The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.

Authors:  Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nat Rev Cancer       Date:  2016-06-03       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.